Raffa Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
Raffa Wealth Management's RDY Position: Q2 2026 in Review
Raffa Wealth Management increased its Dr. Reddy's Laboratories (RDY) stake by 69% in Q2 2026, buying an estimated $3.76K and bringing the position to 683 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #430.
Raffa Wealth Management first reported a position in RDY in Q1 2021 and has held it in 22 quarters since. 226 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Raffa Wealth Management held 683 shares of Dr. Reddy's Laboratories worth $9.9K as of Q2 2026.
- Raffa Wealth Management bought 279 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $3.76K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #430 holding.
- Raffa Wealth Management first reported a position in Dr. Reddy's Laboratories in Q1 2021 and has held it in 22 quarters since.
- 226 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.